Jane Street
ROIV icon

Jane Street’s Roivant Sciences ROIV Stock Holding History

Jane Street’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$998K Sell
28,205
-992,502
-97% -$29.3M ﹤0.01% 6553
2026
Q1 		$28.3M Sell
1,020,707
-290,878
-22% -$7.47M ﹤0.01% 1489
2025
Q4 		$28.5M Sell
1,311,585
-1,434,187
-52% -$28.3M ﹤0.01% 1305
2025
Q3 		$41.5M Buy
2,745,772
+1,524,022
+125% +$18.9M 0.01% 1063
2025
Q2 		$13.8M Buy
1,221,750
+688,881
+129% +$7.47M ﹤0.01% 1802
2025
Q1 		$5.38M Buy
532,869
+502,311
+1,644% +$5.43M ﹤0.01% 2835
2024
Q4 		$362K Buy
30,558
+15,962
+109% +$189K ﹤0.01% 7409
2024
Q3 		$168K Sell
14,596
-2,493,187
-99% -$28.4M ﹤0.01% 8752
2024
Q2 		$26.5M Buy
2,507,783
+1,806,506
+258% +$19.8M 0.01% 1079
2024
Q1 		$7.39M Buy
701,277
+386,429
+123% +$4.17M ﹤0.01% 2130
2023
Q4 		$3.54M Sell
314,848
-1,494,423
-83% -$14.6M ﹤0.01% 3367
2023
Q3 		$21.1M Buy
1,809,271
+1,523,117
+532% +$17.2M 0.01% 1054
2023
Q2 		$2.88M Buy
286,154
+41,895
+17% +$375K ﹤0.01% 3559
2023
Q1 		$1.8M Buy
244,259
+155,681
+176% +$1.28M ﹤0.01% 4003
2022
Q4 		$708K Buy
88,578
+73,660
+494% +$410K ﹤0.01% 5557
2022
Q3 		$48K Buy
+14,918
New +$57.8K ﹤0.01% 8951
2022
Q2 		– Sell
-49,897
Closed -$246K – 10692
2022
Q1 		$246K Buy
+49,897
New +$329K ﹤0.01% 8713

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Jane Street's ROIV Position: Q2 2026 in Review

Jane Street reduced its Roivant Sciences (ROIV) stake by 97% in Q2 2026, selling an estimated $29.3M and leaving 28,205 shares worth $998K. The position accounts for ﹤0.01% of the portfolio, ranked #6553.

Jane Street first reported a position in ROIV in Q1 2022 and has held it in 17 quarters since. The position peaked at $41.5M in Q3 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Jane Street held 28,205 shares of Roivant Sciences worth $998K as of Q2 2026.
  • Jane Street sold 992,502 Roivant Sciences shares in Q2 2026, an estimated $29.3M.
  • Roivant Sciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6553 holding.
  • Jane Street first reported a position in Roivant Sciences in Q1 2022 and has held it in 17 quarters since.
  • Jane Street's Roivant Sciences position peaked at $41.5M in Q3 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.